C4A and COVID-19: C3a, C5a and MAC have been found at high levels in COVID-19 patients, increasing with severity of the disease, together with immunoglobulin IgG and C4 consumption (Gao et al., 2020b; Marcos-Jimenez et al., 2020; Skendros et al., 2020).